Padagis Us patents expiration
1. Clindesse patents expiration
CLINDESSE Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6899890 | PADAGIS US | Bioadhesive drug delivery system |
Apr, 2023
(5 months ago) | |
| US9789057 | PADAGIS US | Pharmaceutical delivery system |
Dec, 2026
(3 years from now) | |
Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 30 November, 2004
Treatment: Method of treating bacterial vaginosis
Dosage: CREAM;VAGINAL
How can I launch a generic of CLINDESSE before it's drug patent expiration?
More Information on Dosage
CLINDESSE family patents
2. Evamist patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6978945 | PADAGIS US | Dispensing device |
Jul, 2022
(1 year, 1 month ago) | |
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 27 July, 2007
Treatment: NA
Dosage: SPRAY;TRANSDERMAL
More Information on Dosage
EVAMIST family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic